Legalization Advocates urge against New Hampshire ‘poison pill’ cannabis bill The legislation would outlaw infused products like edibles Nick LabaMarch 28, 2022
Canada Cannabis Amnesty partners with pot companies to help communities affected by prohibition A new internship program is sponsored by TOQi Technologies and Aurora Natalia Buendia CalvilloMarch 28, 2022
Business Isracann to buy Canadian natural medicine firm of $4M Praesidio Health develops formulations with cannabinoids and psilocybin Nick LabaMarch 28, 2022
Legalization US Senate approves bill to expand cannabis research, House schedules MORE Act for discussion Multiple pot stocks jumped in response to the news Natalia Buendia CalvilloMarch 25, 2022
Business Eve & Co files for creditor protection, 2 directors resign The company has a significant debt pile and a dwindling cash position Nick LabaMarch 25, 2022
Cannabis Cannabis eases muscle spasms, lowers pain and improves sleep in MS patients: study Existing data is promising, but researchers urge more human trials be done Natalia Buendia CalvilloMarch 24, 2022
Business 2021 sales up 27% to US$15.4M for Clever Leaves And 2022 is looking like a bright year for international medical cannabis markets Nick LabaMarch 24, 2022
Business Jushi ups Q4 revenue 22% to US$65.9M But the company's CEO says it's already facing economic headwinds this year Natalia Buendia CalvilloMarch 24, 2022
Business Charlotte’s Web reports steep losses in 2021 The firm is still waiting for long-promised CBD product guidelines in the US Nick LabaMarch 24, 2022
Business Cresco Labs boosts annual sales 73% to US$821.7M But the firm acknowledges a market slowdown in Q4 it was 'not immune to' Nick LabaMarch 23, 2022